X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

    Continuous Bioprocessing Market to Surge by 2028

    Advancing Asia-Pacific Healthcare & Biopharma Innovation

    Generative AI in Pharma: Opportunities & Challenges

    Global Biopharma Market to Hit $566B by 2032

    AI Boosts Small Molecule Therapies for I&I Diseases

    Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

    Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

    Continuous Bioprocessing Market to Surge by 2028

    Advancing Asia-Pacific Healthcare & Biopharma Innovation

    Generative AI in Pharma: Opportunities & Challenges

    Global Biopharma Market to Hit $566B by 2032

    AI Boosts Small Molecule Therapies for I&I Diseases

    Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

    Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

CDC Suggests Majority of Americans Have COVID-19 Antibodies

Content Team by Content Team
3rd May 2022
in News
Ensovibep Therepeutic Candidate To Fight COVID-19 Makes Way

According to updated information from the US Centers for Disease Control and Prevention, about 60% of adults plus 75% of children have antibodies suggesting that they’ve been exposed to COVID-19.

The information comes from a long-term examination of blood specimens sent out to commercial labs across the United States. At the beginning of December, an estimated 34% of Americans had antibodies suggesting that they had been exposed to the virus that induces Covid-19. After an outpouring of cases caused by the Omicron strain, that number had grown to 58 percent by the end of February. Dr. Kristie Clarke, a paediatrician who headed the study for the CDC, said, the biggest surge in antibody detection was among children and teens.

According to the study, over 75% of kids under the age of 18 had acquired antibodies to COVID-19 by February. Adults 65 and older saw the lowest rise, with the CDC estimating that 33 percent of elders have indeed been affected by the virus. However, it’s unknown what these test results indicate in terms of personal or community resistance to future diseases. Researchers really don’t know how much longer virus-induced immunity lasts, and one can’t tell from the study whether all people who screened positive for SARS-CoV-2 antibodies are still shielded from their previous infection, Clarke said.

As a result, the CDC advises that all Americans keep up to date on their COVID-19 immunizations and receive the required shots and boosters. Clarke says people who have been diagnosed within the last three months may be willing to wait on their second booster shot.

The figures are based on random, anonymous blood tests conducted by commercial laboratories in the United States. The testing detects antibodies to components of the virus that causes COVID-19; as vaccinations do not produce these antibodies, the testing is used to determine how many people have been infected with the SARS-CoV-2 virus. According to the CDC, the antibodies used in the study stay positive for at least 2 years following exposure, indicating that the study should capture infections that have occurred since the start of the pandemic.

According to Clarke, the CDC does not advise anyone to get an antibody test. They don’t encourage this on an individual basis, she explained, since it doesn’t change the advice in terms of what one should do, such as getting the vaccines up to date and addressing other precautionary actions with the doctor.

The research comes as more contagious new strains, BA.2 and BA.2.12.1, are taking control of transmission in the United States, producing more cases and hospitalizations. Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention, said that the department is closely monitoring COVID-19 instances in the Northeast. They are seeing a larger number of cases in various parts of the country, especially in the Northeast, and they are also beginning to see some hospital admissions go up, she added.

Walensky explained that the numbers had not risen as quickly as they would have previously in the pandemic, thanks to, she believes, a great level of community protection and vaccinations. However, one must keep a close eye on this, she explained.

Previous Post

Camzyos, Possible Mega Cardiac Drug Given Green Light By FDA

Next Post

Teva And Lupin Reach Settlement In AUSTEDO Patent Dispute

Related Posts

Clinical Trials

Bio-Rad to Acquire Stilla Technologies by Q3 2025

28th February 2025
News

Types of Pharmaceutical Waste and How to Dispose of Them

31st December 2024
Developing Pharma Skills With Life Sci For Growth Initiative
News

UK Medicine Manufacturing Regulatory Framework For Care

6th November 2024
News

Nanoemulsion Drug Delivery Enhances Tuberculosis Care

6th November 2024
News

The Future of Drug Delivery Systems In Modern Medicine

6th November 2024
Revolutionizing Drug Discovery With AI For A Greener Future
News

AI and Nanotech Innovations in Advancing Drug Discovery

5th November 2024
Next Post

Teva And Lupin Reach Settlement In AUSTEDO Patent Dispute

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In